Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients
Özet
Objective: Apoptosis is programmed cell death that occurs by several pathways. Caspase-3 is induced by active caspase-9 via the intrinsic pathway. The aim of this research was to explore the expression of caspase-3 and caspase-9 in schizophrenia patients and healthy samples. Methods: RNA was isolated from the peripheral blood of 39 schizophrenia patients’ and healthy samples. After cDNA synthesis, real time PCR (RT-PCR) was used to analyse caspase-3 and caspase-9 gene expression. The severity of psychopathological symptoms of schizophrenia was evaluated using the Positive and Negative Symptoms Scale for schizophrenia (PANSS) and Clinical Global Impressions (CGI). Results: The expression of caspase-3 and caspase-9 genes was higher in schizophrenia patients than in healthy samples (p = 0.012, p = 0.002, respectively). The increase in caspase-3 gene expression was significant with being male, smoking and with a duration of less than 6 years (p = 0.047, p = 0.049, p = 0.034, respectively). On the other hand, the increase in caspase-9 gene expression was significant in patients who is smoke, have children, and are under 33 years old (p = 0.040, p = 0.043, p = 0.045, respectively). A significant positive correlation was detected between the caspase-3 and caspase-9 gene expression (r = 0.3218, p = 0.049). Conclusion: Our findings indicate that caspase-3 and caspase-9 gene expression may activate cell death mechanisms by intrinsic apoptotic genes. Furthermore, caspase-3 and caspase-9 may play essential roles in different ways in schizophrenia. Hence there is a need to further study the apoptotic mechanism with expanded patient populations.
Anahtar Kelimeler
- Scopus
- 45
- WoS
- 47
- OpenAlex
- 42
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Dirican, Ebubekir | |
| dc.contributor.author | Özcan, Halil | |
| dc.contributor.author | Uzunçakmak, Sevgi Karabulut | |
| dc.contributor.author | Takım, Uğur | |
| dc.date.accessioned | 2026-10-29T19:08:44.326045403Z | |
| dc.date.available | 2026-10-29T19:08:44.326045403Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Objective: Apoptosis is programmed cell death that occurs by several pathways. Caspase-3 is induced by active caspase-9 via the intrinsic pathway. The aim of this research was to explore the expression of caspase-3 and caspase-9 in schizophrenia patients and healthy samples. Methods: RNA was isolated from the peripheral blood of 39 schizophrenia patients’ and healthy samples. After cDNA synthesis, real time PCR (RT-PCR) was used to analyse caspase-3 and caspase-9 gene expression. The severity of psychopathological symptoms of schizophrenia was evaluated using the Positive and Negative Symptoms Scale for schizophrenia (PANSS) and Clinical Global Impressions (CGI). Results: The expression of caspase-3 and caspase-9 genes was higher in schizophrenia patients than in healthy samples (p = 0.012, p = 0.002, respectively). The increase in caspase-3 gene expression was significant with being male, smoking and with a duration of less than 6 years (p = 0.047, p = 0.049, p = 0.034, respectively). On the other hand, the increase in caspase-9 gene expression was significant in patients who is smoke, have children, and are under 33 years old (p = 0.040, p = 0.043, p = 0.045, respectively). A significant positive correlation was detected between the caspase-3 and caspase-9 gene expression (r = 0.3218, p = 0.049). Conclusion: Our findings indicate that caspase-3 and caspase-9 gene expression may activate cell death mechanisms by intrinsic apoptotic genes. Furthermore, caspase-3 and caspase-9 may play essential roles in different ways in schizophrenia. Hence there is a need to further study the apoptotic mechanism with expanded patient populations. | |
| dc.identifier.doi | 10.9758/cpn.2023.21.1.171 | |
| dc.identifier.eissn | 2093-4327 | |
| dc.identifier.endpage | 178 | |
| dc.identifier.issn | 1738-1088 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmcid | PMC9889905 | |
| dc.identifier.pmid | 36700323 | |
| dc.identifier.scopus | 2-s2.0-105011323264 | |
| dc.identifier.startpage | 171 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/bayburt/11734 | |
| dc.identifier.volume | 21 | |
| dc.identifier.wos | WOS:000928396500012 | |
| dc.language.iso | en | |
| dc.publisher | Korean College of Neuropsychopharmacology | |
| dc.relation.ispartof | Clinical Psychopharmacology and Neuroscience | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Apoptosis | |
| dc.subject | Caspase-3 | |
| dc.subject | Caspase-9 | |
| dc.subject | Intrinsic pathway | |
| dc.subject | Real time PCR | |
| dc.subject | Schizophrenia | |
| dc.subject.classification | Neurosciences | |
| dc.subject.classification | Pharmacology & Pharmacy | |
| dc.subject.classification | Neurosciences & Neurology | |
| dc.subject.other | BCL-2 | |
| dc.subject.other | BAX | |
| dc.subject.other | EVENTS | |
| dc.subject.other | STRESS | |
| dc.subject.other | DEATH | |
| dc.subject.other | LIFE | |
| dc.title | Evaluation Expression of the Caspase-3 and Caspase-9 Apoptotic Genes in Schizophrenia Patients | |
| dc.type | Article | |
| rdl.citation.openalex | 42 | |
| rdl.citation.scopus | 45 | |
| rdl.citation.wos | 47 | |
| rdl.department | Health Services Vocational School, Bayburt University, Bayburt, Turkey | |
| rdl.department | Department of Mental Health and Related Disorders, Faculty of Medicine, Atatürk University, Erzurum, Turkey | |
| rdl.oa.status | gold | |
| rdl.oa.status | green | |
| rdl.oa.url | https://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2023.21.1.171 | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

